Treatment for inflammatory bowel disease (IBD) has come a long way, especially over the last 20 years. Today’s therapies offer better control of symptoms and the potential for longer periods of remission. However, finding the right treatment can take time. What works for you may not work for so...

Katy Bagnato was diagnosed with ulcerative colitis in 2010 when she was a freshman in high school. Until last month, Katy had never been in clinical remission, although there were times when she thought that might be the case because she wasn’t having symptoms. There were periods when I thought...

If you have Crohn’s disease or ulcerative colitis, infusion therapy may become part of your treatment regimen to manage your disease. There are many ways you can receive your infusion therapy – read on to learn more about how infusion therapy may be used to treat IBD, your options for where to get a...

If you have Crohn’s disease or ulcerative colitis, then you know how hard it can be to pay for your medication. A Foundation study found that people with inflammatory bowel disease (IBD), especially Crohn’s, pay three times the total health care costs and double the out-of-pocket expenses than peopl...

Ever wonder what fecal microbiota transplantation is? Check out our latest vlog featuring Dr. Neil Nandi, Director of the Inflammatory Bowel Disease Center at Drexel University, College of Medicine. Back to Clinical Trials Community > 

On May 30th of this year, the Food and Drug Administration (FDA) approved a new treatment for moderately to severely active ulcerative colitis.  Tofacitinib, which is made by Pfizer Labs, was previously approved in 2012 for rheumatoid arthritis and in 2017 for psoriatic arthritis. The F...